NantHealth will be exhibiting its Connected Care solutions at booth
#14003
CULVER CITY, Calif. & LAS VEGAS--(BUSINESS WIRE)--
NantHealth
(NASDAQ: NH), a next-generation, evidence-based, personalized healthcare
company, will be exhibiting this year at the Healthcare Information &
Management Systems Society Annual Conference & Exhibition 2018 (HIMSS18)
taking place March 5-9 at the Venetian – Palazzo – Sands Expo Center in
Las Vegas, NV at booth #14003.
NantHealth will be presenting “The
Future of Device Connectivity Across the Continuum of Care” in the
Population Health Solutions Lab, Session SL20, on Wednesday, March 7,
2018 at 10:30 AM Pacific Time. Presenter Wesley
Madden BSN RN, VP of Connectivity Sales, will highlight NantHealth’s
Connected Care solutions today, what the future holds for products in
this category, and how this technology has the potential to dramatically
improve care delivery, clinician satisfaction, and cost reduction
efforts.
In addition, NantHealth representatives will be exhibiting Connected
Care, a portfolio of medical device integration (MDI) products that
include:
-
DeviceConX™
– The award-winning, software-based, and vendor-agnostic Medical
Device Data System (MDDS) trusted by hospitals and clinics across the
globe to facilitate the integration of hundreds of medical devices
with a variety of clinical system endpoints (including popular EHRs).
-
VitalsConX
– A touch-optimized tablet application that streamlines low-acuity
rounding and assessment workflows by eliminating transcription,
accelerating data availability, and collecting both device data and
observations at the bedside and sending them to the EHR in near
real-time.
-
HBox®
– An IEC60601-compliant fanless PC appliance that acts as hub to
capture and relay medical device data from hospital, ambulatory, or
home settings.
“As patient needs are shaping the future of healthcare, technology
continues to play an integral role in supporting this shift,” said
Wesley Madden. “The Connected Care solutions NantHealth is showcasing at
HIMSS 2018 integrate medical device data into clinical records and are
proven to have an impact on length of hospital overstays, costly medical
errors, provider dissatisfaction, and suboptimal patient care.”
Visit NantHealth at booth #14003 in the Population Health Solutions Lab
to see a Connected Care demonstration. or attend the presentation in the
Population Health Solutions Lab. To schedule a private meeting with a
sales, product, or marketing representative please enter your
information here.
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including, among others, statements regarding the capabilities and
anticipated utility of our GPS Cancer, including predicting patient
response and resistance to therapeutics, enabling diagnoses by
physicians and accelerating efforts to bring novel combinations of
therapeutic agents to cancer patients. Forward-looking statements are
subject to numerous risks and uncertainties that could cause actual
results to differ materially from currently anticipated results. Factors
that may cause future results to differ materially from management’s
current expectations include, among other things, that GPS Cancer may
not perform as anticipated, that sufficient physicians may not adopt GPS
Cancer to assist their diagnoses or that healthcare payers may not
provide reimbursement for GPS Cancer as expected. Our business is
subject to numerous additional risks and uncertainties, including, among
others, risks relating to market acceptance of our products; our ability
to successfully launch new products and applications; competition; our
sales, marketing and distribution capabilities; our planned sales,
marketing, and research and development activities; unanticipated
increases in costs or expenses; and risks associated with international
operations. Information on these and additional risks, uncertainties,
and other information affecting our business and operating results can
be found in our existing and future filings with the Securities and
Exchange Commission. These forward-looking statements speak only as of
the date hereof. We disclaim any obligation to update these
forward-looking statements except as may be required by law.
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a
next-generation, evidence-based, personalized healthcare company
enabling improved patient outcomes and more effective treatment
decisions for critical illnesses. NantHealth's unique systems-based
approach to personalized healthcare applies novel diagnostics tailored
to the specific molecular profiles of patient tissues and integrates
this molecular data in a clinical setting with large-scale, real-time
biometric signal and phenotypic data to track patient outcomes and
deliver precision medicine. For nearly a decade, NantHealth has
developed an adaptive learning system, which includes its unique
software, middleware and hardware systems infrastructure that collects,
indexes, analyzes and interprets billions of molecular, clinical,
operational and financial data points derived from novel and traditional
sources, continuously improves decision-making and further optimizes our
clinical pathways and decision algorithms over time. For more
information please visit www.nanthealth.com and
follow Dr. Soon-Shiong on Twitter @DrPatSoonShiong.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180305006139/en/
NantHealth Media Contact
NantWorks
Jen Hodson
jhodson@nantworks.com
Source: NantHealth, Inc.